Skip to main content

Table 1 Baseline characteristics of children admitted with severe pneumonia, Mulago Hospital

From: Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial

Variable

Zinc group N = 176 N (%)

Placebo group N = 176 N (%)

   Sex: Female

78 (44.3)

76 (43.2)

   Age in months 6 to 12

76 (43.2)

68 (38.6)

13 to 59

100 (56.8)

108 (61.4)

Mean age (SD)

17.9 (12.2)

18.1 (11.8)

   Care taker: Mother

152 (87.4)

163 (94.2)

Other

22 (12.6)

10 (31.3)

   Distance: < 5 km

65 (39.4)

70 (41.7)

≥5 km

100 (60.6)

98 (58.3)

   Breastfeeding at six months Yes

40 (80.0)

39 (73.6)

No

10 (20.0)

14 (26.4)

   Measles vaccination: Yes

103 (83.1)

107 (80.5)

No

21 (16.9)

26 (19.6)

Inability to feed (%)

25 (14.3)

25 (14.2)

Duration of cough in days (IQR)

7.0 (4.0 to 14.0)

7.0 (3.0 to 14.0)

Oxygen saturation (IQR)

95.0 (91.0 to 97.0)

94.0 (90.0 to 98.0)

Oxygen saturation at enrolment < 92%

48 (27.7)

54 (31.4)

≥92%

125 (72.3)

118 (68.6)

   Crepitations: Yes

140 (80.0)

147 (84.0)

No

35 (20.0)

28 (16.0)

   WHZ <-2SD

30 (17.1)

40 (22.9)

≥-2SD

146 (83.0)

135 (77.1)

   HAZ <-2SD

46 (26.1)

44 (25.1)

≥-2SD

130 (73.9)

131 (74.9)

   HIV Positive

28 (17.8)

27 (17.5)

Negative

129 (82.2)

127 (82.5)

   Malaria (n = 343): Positive

18 (10.5)

19 (11.0)

Negative

153 (89.5)

153 (89.0)

Blood culture: positive

19(20.2)

26(28.9)

negative

75(79.8)

64(71.1)

Zinc in μmol/L (IQR)

4.4 (1.3 to 8.0)

4.8 (2.3 to 10.4)

  1. HAZ, height for age z score; IQR, inter-quartile range; WAZ, weight for age z score